SCHEMBL5484638

SCHEMBL5484638

O=P(O)(O)c1ccc2ccccc2n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.47
MGAM O43451 1/20 0.47
MAPT P10636 2/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
NCF1 P14598 3/20 0.43
CYP1A2 P05177 2/20 0.43
NOS2 P35228 1/20 0.43
BACE1 P56817 1/20 0.43
CA12 O43570 1/20 0.43
CA9 Q16790 1/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
CNR2 P34972 1/20 0.43
KDM4C Q9H3R0 1/20 0.41
KDM4E B2RXH2 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31552901 1.00 HDAC8 (0.47) HDAC8MGAMMAPTALDH1A1GAA
Nitrogen SCHEMBL27690667 0.96 HDAC8 (0.44) HDAC8MGAMMAPTALDH1A1GAA
SCHEMBL16401204 0.76 MGAM (0.48) HDAC8MGAMMAPTALDH1A1GAA
SCHEMBL30382206 0.76 MGAM (0.48) HDAC8MGAMMAPTALDH1A1GAA
Phosphoric Acid SCHEMBL27545223 0.75 HDAC8 (0.47) HDAC8MGAMMAPTALDH1A1GAA
SCHEMBL7355299 0.73 ALDH1A1 (0.48) ALDH1A1GAASMN1; SMN2KDM4E
Phosphoric Acid SCHEMBL28023255 0.73 NCF1 (0.47) HDAC8MGAMMAPTALDH1A1GAA
Phosphoric Acid SCHEMBL29119725 0.73 NCF1 (0.47) HDAC8MGAMMAPTALDH1A1GAA
Phosphoric Acid SCHEMBL4552489 0.73 BACE1 (0.76) HDAC8MGAMMAPTALDH1A1GAA
SCHEMBL1585265 0.73 PGK1 (0.58) HDAC8MGAMMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5277788-A Twice-anodized aluminum article having an organo-phosphorus monolayer and process for making the article ALUMINUM COMPANY OF AMERICA (US) 1994-01-11 US claimed
EP-0244167-B1 IMPROVED PROCESS FOR PREPARING POLY (ARYL ETHERS) AND POLY (ARYL ETHER KETONES) AMOCO CORPORATION (US) 1990-04-04 EP claimed
US-7176011-B2 Lipid cleavage enzyme HEIDELBERG PHARMA AG (DE) 2007-02-13 US disclosed
US-20030082167-A1 Lapid cleavage enzyme HEIDELBERG PHARMA HOLDING GMBH 2003-05-01 US disclosed
US-20020106363-A1 LIPID CLEAVAGE ENZYME HEIDELBERG PHARMA HOLDING GMBH (DE) 2002-08-08 US disclosed
US-5277788-A Twice-anodized aluminum article having an organo-phosphorus monolayer and process for making the article ALUMINUM COMPANY OF AMERICA (US) 1994-01-11 US disclosed
US-4163850-A BACTERICIDES FOR WATER TREATMENT PETROLITE CORPORATION (US) 1979-08-07 US disclosed
US-4101654-A BACTERIAL GROWTH INHIBITION PETROLITE CORPORATION (US) 1978-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082167-A1 Lapid cleavage enzyme LAP3, NAALAD2, ENGASE HDAC8 1303/4885MGAM 59/4885MAPT 3940/4885
US-20020106363-A1 LIPID CLEAVAGE ENZYME SMPD1, MMEL1, ENGASE HDAC8 1114/4885MGAM 45/4885MAPT 4749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.